PERSPECTA

News from every angle

← Back to headlines

IN8bio Reports GAAP EPS of -$0.26

IN8bio, a clinical-stage biopharmaceutical company, announced its GAAP EPS of -$0.26, indicating its financial performance for the reported period.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphaafr1h ago

IN8bio GAAP EPS of -$0.26

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Oil companies losing Rs 30,000 crore a month on petrol, diesel, LPG sales due to price freeze amid West Asia crisis

10m ago

Fiera Capital Reports Q1 GAAP EPS of $0.38 and Revenue of $153.3M

15m ago

Soligenix Reports Q1 GAAP EPS of $0.28

17m ago